Technique changes risk factors


Fs-laser cataract surgeons cautioned about capsular block syndrome.

However, by maintaining awareness of the changes in the intraocular environment and adopting modifications in their technique, surgeons performing laser cataract surgery can reduce or even eliminate the likelihood of experiencing a case of capsular block syndrome, said Dr Lawless, medical director, Vision Eye Institute, Chatswood, New South Wales, Australia.

Dr Lawless reviewed the development of capsular block syndrome in two eyes that were among the first 50 laser cataract surgery cases performed at the Vision Eye Institute, Sydney, Australia. Both cases occurred on the same day in the hands of a colleague who Dr Lawless described as an experienced and skilled cataract surgeon.

"Different gas patterns are produced within the lens when using the femtosecond laser for capsulotomy and lens fragmentation, but when the nucleus is dense, the gas tends to accumulate behind the nucleus," Dr Lawless said. "The perfect capsulotomy created using the femtosecond laser results in a tight barrier to fluid egress during hydrodissection. These conditions, together with the fact that hydrodissection is usually done quite vigorously in eyes with a dense nucleus, create a perfect storm for blowing out the posterior capsule.

"After these two events, we fully investigated the complications and reported them to the FDA and Australian regulatory agency authorities," he said. "We have also reported our experience in the literature1, and we hope that by reporting on the complication it won't happen to other surgeons. It has not happened in our hands since these first two cases."

Dr Lawless presented a video from the first case that showed the lens fragmentation was performed with what had become routine settings so that its limits were 1 mm anterior to the posterior capsule and 0.5 mm posterior to the anterior capsule.

After the patient was transferred to the operating room, the corneal incisions were opened, ophthalmic viscoelastic device (OVD) was injected into the anterior chamber, which deepened normally, and the capsular disc was removed. There was no evidence of an anterior capsular tear.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.